A study which found personalized dosing of prostate cancer resulted in improved patient outcomes was presented during the Society of Nuclear Medicine and Molecular Imaging 2023 Annual Meeting, SNMMI 2023, held June 24-27 in Chicago, IL.
By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes.
Personalized dosing in prostate cancer treatment found to improve patient outcomes medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.